Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Anti Hypertensive Drugs Companies

Antihypertensive drugs, also known as antihypertensives, are medications designed to treat high blood pressure. Several pharmaceutical companies are actively involved in the research, development, and production of antihypertensive medications.

Antihypertensive Drugs Key Companies Latest AntiHypertensive Drugs Companies Update

Sep 2023
In a phase 2 randomized controlled study, persons with uncontrolled hypertension who received once-daily therapy with the specific aldosterone synthase inhibitor lorundrostat (Mineralys Therapeutics) had a safe and significant reduction in blood pressure. The medicine lowered seated automated workplace systolic blood pressure significantly more than placebo eight weeks following adding lorundrostat (50 mg or 100 mg once daily) or placebo (−9.6 mm Hg with 50 mg; −7.8 mm Hg with 100 mg), with the strongest effects observed in adults with obesity. Overproduction of aldosterone is linked to excessive blood pressure in persons with obesity and related conditions like metabolic syndrome and obstructive sleep apnea.

Nov 2023Additional results for aprocitentan, Idorsia's experimental dual endothelin receptor antagonist, which is used to treat people who have resistant hypertension, were presented orally, according to a statement released by Idorsia Ltd. Patients with hypertension can frequently successfully manage their blood pressure by taking medicine as prescribed and leading a healthy lifestyle. However, 10% of individuals develop resistant hypertension, which is characterized by high blood pressure even after taking at least three antihypertensive drugs at recommended dosages that belong to various pharmacological groups, including a diuretic. Aprocitentan has been shown in the Phase 3 PRECISION research to be safe and effective in lowering blood pressure (BP) in patients with resistant hypertension who are using at least three distinct classes of antihypertensive medicines, including diuretics.

List of AntiHypertensive Drugs Key companies in the market

Medtronic Inc (Ireland)

Abbott Laboratories (US)

Stryker Corporation (US)

DePuy Synthes (US)

B. Braun Melsungen AG (Germany)

NuVasive, Inc (US)

Zimmer Biomet (US)

Orthofix (US)

Globus Medical (US)

Anti Hypertensive Drugs Market Highlights:

Anti Hypertensive Drugs Market Size

Anti Hypertensive Drugs Market Trends

Anti Hypertensive Drugs Market Analysis

Anti Hypertensive Drugs Market Share

Anti Hypertensive Drugs Market Highlights:

Anti Hypertensive Drugs Market Trends

Anti Hypertensive Drugs Market Analysis

Anti Hypertensive Drugs Market Share

Anti Hypertensive Drugs Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.